Manuel Tsiang

3.1k total citations
47 papers, 2.6k citations indexed

About

Manuel Tsiang is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Manuel Tsiang has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Molecular Biology and 22 papers in Virology. Recurrent topics in Manuel Tsiang's work include HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (22 papers) and Biochemical and Molecular Research (13 papers). Manuel Tsiang is often cited by papers focused on HIV/AIDS drug development and treatment (23 papers), HIV Research and Treatment (22 papers) and Biochemical and Molecular Research (13 papers). Manuel Tsiang collaborates with scholars based in United States, France and Russia. Manuel Tsiang's co-authors include J. Evan Sadler, Steven R. Lentz, Craig S. Gibbs, Qingyu Wu, G.S. Jones, John J. Toole, James F. Rooney, Kyla Dunn, Sondra Schlesinger and Haolun Jin and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Manuel Tsiang

46 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Tsiang United States 29 870 845 731 689 553 47 2.6k
Craig S. Gibbs United States 36 1.2k 1.3× 1.3k 1.5× 405 0.6× 341 0.5× 2.7k 4.9× 66 4.7k
Charles M. Heldebrant United States 15 858 1.0× 270 0.3× 481 0.7× 913 1.3× 522 0.9× 23 2.0k
Chiara Agrati Italy 31 872 1.0× 397 0.5× 62 0.1× 326 0.5× 671 1.2× 141 2.8k
Dorian Bevec Austria 32 247 0.3× 1.4k 1.7× 146 0.2× 442 0.6× 207 0.4× 62 2.9k
Thomas Lavstsen Denmark 33 209 0.2× 754 0.9× 217 0.3× 588 0.9× 374 0.7× 81 4.9k
Masanori Isogawa Japan 30 618 0.7× 524 0.6× 164 0.2× 132 0.2× 2.7k 4.8× 61 4.2k
Hartmut J. Ehrlich Austria 31 699 0.8× 485 0.6× 878 1.2× 51 0.1× 798 1.4× 113 2.9k
Tsutomu Murakami Japan 28 853 1.0× 1.1k 1.3× 62 0.1× 1.5k 2.2× 487 0.9× 132 3.3k
Zhiyuan Yang China 16 506 0.6× 2.5k 2.9× 315 0.4× 936 1.4× 335 0.6× 57 3.6k
Andrea Buchacher Austria 23 604 0.7× 1.3k 1.5× 230 0.3× 1.6k 2.3× 281 0.5× 46 3.0k

Countries citing papers authored by Manuel Tsiang

Since Specialization
Citations

This map shows the geographic impact of Manuel Tsiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Tsiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Tsiang more than expected).

Fields of papers citing papers by Manuel Tsiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Tsiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Tsiang. The network helps show where Manuel Tsiang may publish in the future.

Co-authorship network of co-authors of Manuel Tsiang

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Tsiang. A scholar is included among the top collaborators of Manuel Tsiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Tsiang. Manuel Tsiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abram, Michael E., Manuel Tsiang, Kirsten White, Christian Callebaut, & Michael D. Miller. (2014). A Cell-Based Strategy To Assess Intrinsic Inhibition Efficiencies of HIV-1 Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy. 59(2). 838–848. 1 indexed citations
2.
Tsiang, Manuel, G.S. Jones, Anita Niedziela‐Majka, et al.. (2012). New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action. Journal of Biological Chemistry. 287(25). 21189–21203. 129 indexed citations
3.
Tsiang, Manuel, G.S. Jones, Magdeleine Hung, et al.. (2011). Dithiothreitol Causes HIV-1 Integrase Dimer Dissociation While Agents Interacting With the Integrase Dimer Interface Promote Dimer Formation. Biochemistry. 50(10). 1567–1581. 15 indexed citations
4.
Jin, Haolun, Matthew Wright, Richard Pastor, et al.. (2008). Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs. Bioorganic & Medicinal Chemistry Letters. 18(4). 1388–1391. 17 indexed citations
5.
Tsiang, Manuel, et al.. (2008). Modeling, Analysis, and Validation of a Novel HIV Integrase Structure Provide Insights into the Binding Modes of Potent Integrase Inhibitors. Journal of Molecular Biology. 380(3). 504–519. 67 indexed citations
6.
Fardis, Maria, Haolun Jin, Salman Jabri, et al.. (2006). Effect of substitution on novel tricyclic HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 4031–4035. 29 indexed citations
7.
Metobo, Sammy, Haolun Jin, Manuel Tsiang, & Choung U. Kim. (2006). Design, synthesis, and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring. Bioorganic & Medicinal Chemistry Letters. 16(15). 3985–3988. 38 indexed citations
8.
Metobo, Sammy, Haolun Jin, Manuel Tsiang, & Choung U. Kim. (2006). Design, Synthesis and Biological Evaluation of Novel Tricyclic HIV‐1 Integrase Inhibitors by Modification of Its Pyridine Ring.. ChemInform. 37(45).
9.
Neumann, Avidan U., Manuel Tsiang, Michael Wulfsohn, et al.. (2003). Predicting HBEAG loss by HBV DNA early kinetics and HBV genotype during treatment of HBEAG+ chronic hepatitis B (CHB) patients with adefovir dipivoxil (ADV). Journal of Hepatology. 38. 26–26. 3 indexed citations
10.
Heathcote, E. Jenny, Quang Minh Thai, Manuel Tsiang, et al.. (2001). Dynamics analyses provide insight into the influence of precore mutations on the mechanisms of viral CL. Journal of Hepatology. 34. 167–168. 2 indexed citations
11.
Tsiang, Manuel, et al.. (2000). Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study. Hepatology. 32(2). 394–399. 148 indexed citations
12.
Colwell, Niall S., Morey A. Blinder, Manuel Tsiang, et al.. (1999). Allosteric Effects of a Monoclonal Antibody against Thrombin Exosite II. Biochemistry. 38(8). 2610–2610. 5 indexed citations
13.
Tsiang, Manuel, James F. Rooney, John J. Toole, & Craig S. Gibbs. (1999). Biphasic Clearance Kinetics of Hepatitis B Virus From Patients During Adefovir Dipivoxil Therapy. Hepatology. 29(6). 1863–1869. 202 indexed citations
14.
Colwell, Niall S., Morey A. Blinder, Manuel Tsiang, et al.. (1998). Allosteric Effects of a Monoclonal Antibody against Thrombin Exosite II. Biochemistry. 37(43). 15057–15065. 28 indexed citations
15.
Tsiang, Manuel, et al.. (1997). Functional Requirements for Inhibition of Thrombin by Antithrombin III in the Presence and Absence of Heparin. Journal of Biological Chemistry. 272(18). 12024–12029. 36 indexed citations
16.
Tsiang, Manuel, Craig S. Gibbs, Linda C. Griffin, Kyla Dunn, & Lawrence Leung. (1995). Selection of a Suppressor Mutation That Restores Affinity of an Oligonucleotide Inhibitor for Thrombin Using in Vitro Genetics. Journal of Biological Chemistry. 270(33). 19370–19376. 48 indexed citations
17.
Gibbs, Craig S., Steven Coutré, Manuel Tsiang, et al.. (1995). Conversion of thrombin into an anticoagulant by protein engineering. Nature. 378(6555). 413–416. 108 indexed citations
18.
Sadler, J. Evan, et al.. (1993). Structure-Function Relationships of the Thrombin-Thrombomodulin Interaction. Pathophysiology of Haemostasis and Thrombosis. 23(Suppl. 1). 183–193. 56 indexed citations
19.
Tsiang, Manuel, Steven R. Lentz, & J. Evan Sadler. (1992). Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity.. Journal of Biological Chemistry. 267(9). 6164–6170. 88 indexed citations
20.
Tsiang, Manuel, et al.. (1990). Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogs. Biochemistry. 29(47). 10602–10612. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig S. Gibbs Breakdown of academic impact, for papers by Charles M. Heldebrant Breakdown of academic impact, for papers by Chiara Agrati Breakdown of academic impact, for papers by Dorian Bevec Breakdown of academic impact, for papers by Thomas Lavstsen Breakdown of academic impact, for papers by Masanori Isogawa Breakdown of academic impact, for papers by Hartmut J. Ehrlich Breakdown of academic impact, for papers by Tsutomu Murakami Breakdown of academic impact, for papers by Zhiyuan Yang Breakdown of academic impact, for papers by Andrea Buchacher
Rankless by CCL
2026